MarketCap
Facebook
X
TelegramDicerna Pharmaceuticals, Inc. Finanzkreislauf | DRNA
Finanzkreislauf Jährlich Dicerna Pharmaceuticals, Inc.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 26.4 | 68.6 | 16.6 | -66.1 | -32.5 | -62.5 | -72.2 | 160 | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 160 | -72.2 | 4.8 |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
CNS Pharmaceuticals
CNSP
|
-13.6 K | $ 3.62 | -5.97 % | $ 1.6 M |  USA |
 |
Trevena
TRVN
|
-412 | - | -46.58 % | $ 31.8 M | USA |
 |
Calithera Biosciences
CALA
|
28.8 | - | -10.95 % | $ 876 K | USA |
 |
Wave Life Sciences Ltd.
WVE
|
11.5 | $ 3.42 | -0.15 % | $ 577 M |  Singapore |
 |
Exicure
XCUR
|
-4.16 | $ 1.05 | -2.78 % | $ 6.61 M | USA |
 |
Xeris Pharmaceuticals
XERS
|
535 | $ 16.51 | 4.3 % | $ 2.65 B | USA |
 |
Molecular Templates
MTEM
|
4.53 | - | -23.43 % | $ 495 K | USA |
 |
22nd Century Group
XXII
|
108 | $ 1.57 | 10.56 % | $ 289 K | USA |
 |
Zai Lab Limited
ZLAB
|
-46.6 | $ 26.42 | -0.04 % | $ 28.9 B |  China |
 |
Zoetis
ZTS
|
317 | $ 82.56 | 0.12 % | $ 36.6 B | USA |
 |
BioXcel Therapeutics
BTAI
|
-32.5 K | $ 0.07 | 9.81 % | $ 855 K | USA |
 |
Navidea Biopharmaceuticals
NAVB
|
-279 K | - | -2.99 % | $ 2.47 M | USA |
 |
BioDelivery Sciences International
BDSI
|
340 | - | -4.8 % | $ 255 M | USA |
 |
Insmed Incorporated
INSM
|
173 | $ 120.63 | 0.95 % | $ 24 B | USA |
 |
Novan
NOVN
|
-159 | - | -24.84 % | $ 2.64 M | USA |
 |
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | USA |
 |
bluebird bio
BLUE
|
72.4 | - | - | $ 546 M | USA |
 |
Intra-Cellular Therapies
ITCI
|
257 | - | - | $ 13.6 B | USA |
 |
Marinus Pharmaceuticals
MRNS
|
59.8 | - | - | $ 29.6 M | USA |
 |
NeuBase Therapeutics
NBSE
|
-65.8 | - | -1.56 % | $ 12.3 M | USA |
 |
CASI Pharmaceuticals
CASI
|
126 | - | - | $ 35.4 M | USA |
 |
ContraFect Corporation
CFRX
|
-1.83 K | - | -5.16 % | $ 5.39 M | USA |
 |
Sigilon Therapeutics
SGTX
|
31.4 | - | - | $ 728 M | USA |
 |
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | USA |
 |
Revance Therapeutics
RVNC
|
30.4 | - | - | $ 309 M | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
492 | $ 4.86 | 1.04 % | $ 787 M | USA |
 |
Epizyme
EPZM
|
-308 | - | - | $ 249 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
8.16 K | - | -6.81 % | $ 3.04 B | USA |
 |
Nabriva Therapeutics plc
NBRV
|
151 | - | - | $ 4.55 M |  Irlanda |
 |
NGM Biopharmaceuticals
NGM
|
18.4 | - | - | $ 127 M | USA |
 |
9 Meters Biopharma
NMTR
|
27.9 | - | -42.97 % | $ 1.05 M | USA |
 |
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M | USA |